Mizuho Securities Adjusts Albemarle Price Target to $140 From $160, Maintains Neutral Rating

Mizuho Securities cut Albemarle's price target to $140 from $160, keeping a Neutral rating. The move aligns with recent leadership updates at the specialty chemicals firm, including Ragnar Udd's appointment as new CEO effective February 2027.